Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate EDAP TMS S.A. before investing.

In this article, we go over a few key elements for understanding EDAP TMS S.A.’s stock price such as:

• EDAP TMS S.A.’s current stock price and volume
• Why EDAP TMS S.A.’s stock price changed recently
• Upgrades and downgrades for EDAP from analysts
• EDAP’s stock price momentum as measured by its relative strength

About EDAP TMS S.A. (EDAP)

Before we jump into EDAP TMS S.A.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.

Want to learn more about EDAP TMS S.A.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about EDAP TMS S.A..

EDAP TMS S.A.’s Stock Price as of Market Close

As of April 09, 2025, 12:17 PM, CST, EDAP TMS S.A.’s stock price was $1.480.

EDAP TMS S.A. is up 1.72% from its previous closing price of $1.455.

During the last market session, EDAP TMS S.A.’s stock traded between $1.360 and $1.570. Currently, there are approximately 38.69 million shares outstanding for EDAP TMS S.A..

EDAP TMS S.A.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

EDAP TMS S.A. Stock Price History

EDAP TMS S.A.’s (EDAP) price is currently down 24.49% so far this month.

During the month of April, EDAP TMS S.A.’s stock price has reached a high of $2.350 and a low of $1.360.

Over the last year, EDAP TMS S.A. has hit prices as high as $8.500 and as low as $1.400. Year to date, EDAP TMS S.A.’s stock is down 33.03%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused EDAP TMS S.A. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of April 08, 2025,, no analysts have changed their rating of EDAP TMS S.A.’s stock over the last month.

Additionally, you'll want to evaluate EDAP TMS S.A.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on EDAP TMS S.A.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

EDAP TMS S.A.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about EDAP TMS S.A. (EDAP) by visiting AAII Stock Evaluator.

Relative Price Strength of EDAP TMS S.A.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 08, 2025, EDAP TMS S.A. has a weighted four-quarter relative price strength of -32.90%, which translates to a Momentum Score of 5 and is considered to be Very Weak.

Want to learn more about how EDAP TMS S.A. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

EDAP TMS S.A. Stock Price: Bottom Line

As of April 9, 2025, EDAP TMS S.A.’s stock price is $1.480, which is up 1.72% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like EDAP TMS S.A. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.